E. Mcnally and P. Pytel, Muscle Diseases: The Muscular Dystrophies, Annual Review of Pathology: Mechanisms of Disease, vol.2, issue.1, pp.87-109, 2007.
DOI : 10.1146/annurev.pathol.2.010506.091936

M. Ruegg and D. Glass, Molecular Mechanisms and Treatment Options for Muscle Wasting Diseases, Annual Review of Pharmacology and Toxicology, vol.51, issue.1, pp.373-395, 2011.
DOI : 10.1146/annurev-pharmtox-010510-100537

C. Trollet, T. Athanasopoulos, L. Popplewell, A. Malerba, and G. Dickson, Gene therapy for muscular dystrophy: current progress and future prospects, Expert Opinion on Biological Therapy, vol.24, issue.7, pp.849-866, 2009.
DOI : 10.1038/sj.gt.3303016

C. Trollet, S. Anvar, A. Venema, I. Hargreaves, K. Foster et al., Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres, Human Molecular Genetics, vol.19, issue.11, 2010.
DOI : 10.1093/hmg/ddq098

A. Vignaud, A. Ferry, A. Huguet, M. Baraibar, C. Trollet et al., Progressive skeletal muscle weakness in transgenic mice expressing CTG expansions is associated with the activation of the ubiquitin???proteasome pathway, Neuromuscular Disorders, vol.20, issue.5, pp.319-325, 2010.
DOI : 10.1016/j.nmd.2010.03.006

V. Allamand and K. Campbell, Animal models for muscular dystrophy: valuable tools for the development of therapies, Human Molecular Genetics, vol.9, issue.16, pp.2459-2467, 2000.
DOI : 10.1093/hmg/9.16.2459

V. Mouly, A. Aamiri, S. Perie, K. Mamchaoui, A. Barani et al., Myoblast transfer therapy: is there any light at the end of the tunnel?, Acta Myol, vol.24, pp.128-133, 2005.

C. Webster and H. Blau, Accelerated age-related decline in replicative life-span of Duchenne muscular dystrophy myoblasts: Implications for cell and gene therapy, Somatic Cell and Molecular Genetics, vol.337, issue.6, pp.557-565, 1990.
DOI : 10.1007/BF01233096

V. Renault, L. Thornell, P. Eriksson, G. Butler-browne, and V. Mouly, Regenerative potential of human skeletal muscle during aging, Aging Cell, vol.222, issue.2, pp.132-139, 2002.
DOI : 10.1046/j.1474-9728.2002.00017.x

W. Wright and J. Shay, Historical claims and current interpretations of replicative aging, Nature Biotechnology, vol.20, issue.7, pp.682-688, 2002.
DOI : 10.1038/nbt0702-682

A. Bodnar, M. Ouellette, M. Frolkis, S. Holt, C. Chiu et al., Extension of Life-Span by Introduction of Telomerase into Normal Human Cells, Science, vol.279, issue.5349, pp.349-352, 1998.
DOI : 10.1126/science.279.5349.349

H. Vaziri and S. Benchimol, Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span, Current Biology, vol.8, issue.5, pp.279-282, 1998.
DOI : 10.1016/S0960-9822(98)70109-5

C. Zhu, V. Mouly, R. Cooper, K. Mamchaoui, A. Bigot et al., Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase 4: consequences in aging muscle and therapeutic strategies for muscular dystrophies, Aging Cell, vol.20, issue.4, pp.515-523, 2007.
DOI : 10.1111/j.1474-9726.2007.00306.x

K. Nowak and K. Davies, Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment, EMBO reports, vol.10, issue.9, pp.872-876, 2004.
DOI : 10.1016/S0960-8966(99)00010-3

R. Tawil, Facioscapulohumeral muscular dystrophy, Neurotherapeutics, vol.25, issue.4, pp.601-606, 2008.
DOI : 10.1016/j.nurt.2008.07.005
URL : https://hal.archives-ouvertes.fr/hal-00770764

B. Brais, J. Bouchard, Y. Xie, D. Rochefort, N. Chretien et al., Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy, Nature Genetics, vol.146, issue.2, pp.164-167, 1998.
DOI : 10.1016/0960-8966(93)90119-5

D. Bansal, K. Miyake, S. Vogel, S. Groh, C. Chen et al., Defective membrane repair in dysferlin-deficient muscular dystrophy, Nature, vol.5, issue.6936, pp.168-172, 2003.
DOI : 10.1083/jcb.137.3.685

U. Reed, Congenital muscular dystrophy. Part I: a review of phenotypical and diagnostic aspects, Arquivos de Neuro-Psiquiatria, vol.67, issue.1, pp.144-168, 2009.
DOI : 10.1590/S0004-282X2009000100038

A. Bigot, A. Klein, E. Gasnier, V. Jacquemin, P. Ravassard et al., Large CTG Repeats Trigger p16-Dependent Premature Senescence in Myotonic Dystrophy Type 1 Muscle Precursor Cells, The American Journal of Pathology, vol.174, issue.4, pp.1435-1442, 2009.
DOI : 10.2353/ajpath.2009.080560

D. Donna, S. Mamchaoui, K. Cooper, R. Seigneurin-venin, S. Tremblay et al., Telomerase can extend the proliferative capacity of human myoblasts, but does not lead to their immortalization, Mol Cancer Res, vol.1, pp.643-653, 2003.

R. Cawthon, Telomere measurement by quantitative PCR, Nucleic Acids Research, vol.30, issue.10, p.47, 2002.
DOI : 10.1093/nar/30.10.e47
URL : http://doi.org/10.1093/nar/30.10.e47

R. Cawthon, Telomere length measurement by a novel monochrome multiplex quantitative PCR method, Nucleic Acids Research, vol.37, issue.3, p.21, 2009.
DOI : 10.1093/nar/gkn1027

E. Negroni, I. Riederer, S. Chaouch, M. Belicchi, P. Razini et al., In Vivo Myogenic Potential of Human CD133+ Muscle-derived Stem Cells: A Quantitative Study, Molecular Therapy, vol.17, issue.10, pp.1771-1778, 2009.
DOI : 10.1038/mt.2009.167

R. Cooper, A. Irintchev, D. Santo, J. Zweyer, M. Morgan et al., A New Immunodeficient Mouse Model for Human Myoblast Transplantation, Human Gene Therapy, vol.12, issue.7, pp.823-831, 2001.
DOI : 10.1089/104303401750148784

R. Cooper, D. Thiesson, D. Furling, D. Santo, J. Butler-browne et al., and Replicative Senescence: Key Factors Implicated in the Success of Human Myoblast Transplantation, Human Gene Therapy, vol.14, issue.12, pp.1169-1179, 2003.
DOI : 10.1089/104303403322168000

S. Decary, V. Mouly, C. Hamida, A. Sautet, J. Barbet et al., Replicative Potential and Telomere Length in Human Skeletal Muscle: Implications for Satellite Cell-Mediated Gene Therapy, Human Gene Therapy, vol.8, issue.12, pp.1429-1438, 1997.
DOI : 10.1089/hum.1997.8.12-1429

V. Renault, G. Piron-hamelin, C. Forestier, S. Didonna, S. Decary et al., Skeletal muscle regeneration and the mitotic clock, Experimental Gerontology, vol.35, issue.6-7, pp.711-719, 2000.
DOI : 10.1016/S0531-5565(00)00151-0

. Mamchaoui, Skeletal Muscle, p.3434, 2011.

A. Bigot, V. Jacquemin, F. Debacq-chainiaux, G. Butler-browne, O. Toussaint et al., Replicative aging down-regulates the myogenic regulatory factors in human myoblasts, Biology of the Cell, vol.6, issue.3, pp.189-199, 2008.
DOI : 10.1042/BC20070085

S. Rossi, P. Poliani, M. Cominelli, A. Bozzato, R. Vescovi et al., Caveolin 1 is a marker of poor differentiation in Rhabdomyosarcoma, European Journal of Cancer, vol.47, issue.5, 2010.
DOI : 10.1016/j.ejca.2010.10.018

S. Wang, L. Guo, L. Dong, S. Li, J. Zhang et al., TGF-??1 signal pathway may contribute to rhabdomyosarcoma development by inhibiting differentiation, Cancer Science, vol.120, issue.5, pp.1108-1116, 2010.
DOI : 10.1111/j.1349-7006.2010.01512.x
URL : http://doi.org/10.1111/j.1349-7006.2010.01512.x

N. Stewart and S. Bacchetti, Expression of SV40 large T antigen, but not small t antigen, is required for the induction of chromosomal aberrations in transformed human cells, Virology, vol.180, issue.1, pp.49-57, 1991.
DOI : 10.1016/0042-6822(91)90008-Y

V. Mouly, F. Edom, S. Decary, P. Vicart, J. Barbert et al., SV40 Large T Antigen Interferes with Adult Myosin Heavy Chain Expression, but Not with Differentiation of Human Satellite Cells, Experimental Cell Research, vol.225, issue.2, pp.268-276, 1996.
DOI : 10.1006/excr.1996.0176

C. Cudre-mauroux, T. Occhiodoro, S. Konig, P. Salmon, L. Bernheim et al., Lentivector-Mediated Transfer of Bmi-1 and Telomerase in Muscle Satellite Cells Yields a Duchenne Myoblast Cell Line with Long-Term Genotypic and Phenotypic Stability, Human Gene Therapy, vol.14, issue.16, pp.1525-1533, 2003.
DOI : 10.1089/104303403322495034

G. Stadler, J. Chen, K. Wagner, J. Robin, J. Shay et al., Establishment of clonal myogenic cell lines from severely affected dystrophic muscles - CDK4 maintains the myogenic population, Skeletal Muscle, vol.1, issue.1, p.12
DOI : 10.1038/289060a0

S. Perie, K. Mamchaoui, V. Mouly, S. Blot, B. Bouazza et al., Premature proliferative arrest of cricopharyngeal myoblasts in oculo-pharyngeal muscular dystrophy: Therapeutic perspectives of autologous myoblast transplantation, Neuromuscular Disorders, vol.16, issue.11, pp.770-781, 2006.
DOI : 10.1016/j.nmd.2006.07.022

S. Chaouch, V. Mouly, A. Goyenvalle, A. Vulin, K. Mamchaoui et al., Immortalized Skin Fibroblasts Expressing Conditional MyoD as a Renewable and Reliable Source of Converted Human Muscle Cells to Assess Therapeutic Strategies for Muscular Dystrophies: Validation of an Exon-Skipping Approach to Restore Dystrophin in Duchenne Muscular Dystrophy Cells, Human Gene Therapy, vol.20, issue.7, pp.784-790, 2009.
DOI : 10.1089/hum.2008.163